- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Metastatic Breast Cancer in United States
Total 26620 results
-
Marina N SharifiNovartis; University of Wisconsin, MadisonRecruitingHormone Receptor Positive Breast Carcinoma | HER2-negative Breast Cancer | PIK3CA Mutant Metastatic Breast CancerUnited States
-
University of California, San FranciscoNational Cancer Institute (NCI)CompletedBreast Cancer | Metastatic CancerUnited States
-
Novartis PharmaceuticalsTerminatedMetastatic Breast Cancer | HER2+ Breast CancerBelgium, France, Spain, United States, United Kingdom, Italy
-
Dantari, Inc.CompletedHER2-negative Metastatic Breast CancerUnited States
-
Novartis PharmaceuticalsCompletedAdvanced or Metastatic Breast CancerSpain, United States
-
Antonio Giordano, MDCardiff OncologyRecruitingBreast Cancer | Metastatic Breast Cancer | Inflammatory Breast Cancer | Invasive Breast Cancer | Locally Advanced Breast Cancer | Unresectable Breast Carcinoma | HER2-negative Breast Cancer | Triple Negative Breast Cancer (TNBC) | Hormone Receptor Negative Breast Carcinoma | Hormone Receptor/Growth Factor...United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedStage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Breast Carcinoma Metastatic in Lymph Node | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7United States
-
Polyphor Ltd.CompletedMetastatic Breast CancerSpain, United States
-
PfizerCompletedBreast Cancer MetastaticArgentina, United Kingdom
-
Royal Marsden NHS Foundation TrustCompletedMetastatic Breast CancerUnited Kingdom
-
Indiana UniversityNational Cancer Institute (NCI); Northwestern University; Indiana University... and other collaboratorsCompleted
-
Sonya ReidSusan G. Komen Breast Cancer Foundation; AgendiaRecruitingMetastatic Breast Cancer | Invasive Mammary CarcinomaUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)CompletedObesity | Metastatic Breast CancerUnited States
-
Heidelberg Pharma AGU.S. Army Medical Research and Development CommandCompletedMetastatic Breast CancerUnited States, Belgium, Brazil, Germany, Israel
-
Memorial Sloan Kettering Cancer CenterUnited States Department of DefenseActive, not recruitingBreast Cancer | Metastatic HER2-negative BreastUnited States
-
Celgene CorporationWithdrawnMetastatic Breast CancerUnited States
-
Eli Lilly and CompanyCompletedCancer | MetastasesUnited States
-
Enzon Pharmaceuticals, Inc.TerminatedMetastatic Breast CancerUnited States
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)RecruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Lung Carcinoma | Stage IV Lung Cancer AJCC v8 | Metastatic Malignant Solid Neoplasm | Metastatic Breast CarcinomaUnited States
-
National Cancer Institute (NCI)RecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Bone | Metastatic HER2-Negative Breast CarcinomaUnited States
-
AmgenCompletedCancer | Breast Cancer | Breast Neoplasms | Metastatic Cancer | Breast Tumors | Solid Tumors | Oncology | Tumors | Metastases | Locally Recurrent and Metastatic Breast CancerUnited States, Belgium, France
-
Royal Marsden NHS Foundation TrustPfizer; Hoffmann-La RocheRecruitingAdvanced Breast Cancer | Metastatic Breast Cancer | ER+ Breast CancerUnited Kingdom
-
Memorial Sloan Kettering Cancer CenterRecruitingHormone Receptor Positive Metastatic Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterAstellas Pharma US, Inc.; Corcept Therapeutics; Breast Cancer Research FoundationRecruitingMetastatic Breast CancerUnited States
-
Sermonix Pharmaceuticals Inc.Active, not recruitingMetastatic Breast CancerUnited States
-
Novartis PharmaceuticalsCompletedMetastatic Breast Cancer (MBC) | Locally Advance Breast Cancer (LABC)United Kingdom, Spain
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IV Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | Metastatic Breast Carcinoma | Locally Advanced Breast Carcinoma | Breast Inflammatory CarcinomaUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...Tibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USATerminatedMetastatic Breast CancerUnited States
-
University of Alabama at BirminghamSusan G. Komen Breast Cancer Foundation; Daiichi Sankyo UK Ltd.; Triple Negative...CompletedBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Stage IV Breast CancerUnited States
-
Prescient Therapeutics, Ltd.VioQuest PharmaceuticalsCompleted
-
Fred Hutchinson Cancer CenterSignalOne Bio, Inc.TerminatedMetastatic Lung Non-Small Cell Carcinoma | Anatomic Stage IV Breast Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Metastatic Malignant Solid Neoplasm | Metastatic Urothelial Carcinoma | Metastatic Triple-Negative Breast CarcinomaUnited States
-
SCRI Development Innovations, LLCEli Lilly and Company; AmgenCompletedMetastatic Breast CancerUnited States
-
Oncolytics BiotechPrECOG, LLC.Active, not recruiting
-
NYU Langone HealthCompleted
-
Novartis PharmaceuticalsTerminatedAdvanced or Metastatic ER+ Breast CancerUnited States, France, Germany, Singapore, Italy, Japan, Belgium
-
UNC Lineberger Comprehensive Cancer CenterConquer Cancer FoundationRecruitingMetastatic Breast Cancer | End of LifeUnited States
-
Ellipses PharmaRecruitingMetastatic Breast Cancer | Hormone Receptor-positive Breast Cancer | Hormone Receptor Positive HER-2 Negative Breast CancerUnited States, Spain, United Kingdom
-
Cota Inc.Blue Cross Blue Shield; NantHealth Inc.TerminatedPancreatic Cancer | Metastatic Lung Cancer | Metastatic Breast Cancer | Metastatic Melanoma | Metastatic Prostate Cancer | Metastatic Colon CancerUnited States
-
US Oncology ResearchTranslational Drug Development; Life Technologies, Inc.CompletedMetastatic Breast Cancer | Triple Negative Breast CancerUnited States
-
CelgeneCompletedMetastatic Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterUniversity of Chicago; New York UniversityActive, not recruitingNon-Metastatic Breast CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)RecruitingCancer | Metastatic | Breast | Triple Negative | Disseminated Tumor CellUnited States
-
ETOP IBCSG Partners FoundationBreast International GroupCompletedPalbociclib in Molecularly Characterized ER-positive/HER2-negative Metastatic Breast Cancer (PYTHIA)Metastatic Breast CancerUnited Kingdom, Belgium, Italy
-
Theodoros FoukakisTerminatedBreast Cancer MetastaticSweden, United Kingdom
-
Eli Lilly and CompanyCompleted
-
University of Southern CaliforniaTerminatedRecurrent Breast Cancer | Metastastic Breast CancerUnited States
-
PfizerTerminatedBreast Cancer MetastaticUnited States, Spain, Belgium, Italy
-
Eli Lilly and CompanyCompletedMetastatic Breast CancerUnited States
-
Novartis PharmaceuticalsCompletedMetastatic Breast CancerBelgium, France, Netherlands, United States, Spain
-
Jules Bordet InstituteBreast International GroupCompletedMetastatic Breast CancerBelgium, Spain, Germany, United Kingdom